Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Temporal variation of eukaryotic community structures in UASB reactor treating domestic sewage as revealed by 18S rRNA gene sequencing.

Hirakata Y, Hatamoto M, Oshiki M, Watari T, Kuroda K, Araki N, Yamaguchi T.

Sci Rep. 2019 Sep 4;9(1):12783. doi: 10.1038/s41598-019-49290-y.

2.

Non-aerated single-stage nitrogen removal using a down-flow hanging sponge reactor as post-treatment for nitrogen-rich wastewater treatment.

Tanikawa D, Yamashita S, Kataoka T, Sonaka H, Hirakata Y, Hatamoto M, Yamaguchi T.

Chemosphere. 2019 Oct;233:645-651. doi: 10.1016/j.chemosphere.2019.06.012. Epub 2019 Jun 4.

PMID:
31195268
3.

Adsorption and biodegradation removal of methylene blue in a down-flow hanging filter reactor incorporating natural adsorbent.

Nguyet PN, Watari T, Hirakata Y, Hatamoto M, Yamaguchi T.

Environ Technol. 2019 Jun 17:1-9. doi: 10.1080/09593330.2019.1629636. [Epub ahead of print]

PMID:
31179878
4.

Ureolytic Prokaryotes in Soil: Community Abundance and Diversity.

Oshiki M, Araki M, Hirakata Y, Hatamoto M, Yamaguchi T, Araki N.

Microbes Environ. 2018 Jul 4;33(2):230-233. doi: 10.1264/jsme2.ME17188. Epub 2018 Apr 28.

5.

Defining microbial community composition and seasonal variation in a sewage treatment plant in India using a down-flow hanging sponge reactor.

Nomoto N, Hatamoto M, Hirakata Y, Ali M, Jayaswal K, Iguchi A, Okubo T, Takahashi M, Kubota K, Tagawa T, Uemura S, Yamaguchi T, Harada H.

Appl Microbiol Biotechnol. 2018 May;102(10):4381-4392. doi: 10.1007/s00253-018-8864-1. Epub 2018 Mar 28.

PMID:
29594342
6.

A nitrogen removal system to limit water exchange for recirculating freshwater aquarium using DHS-USB reactor.

Adlin N, Matsuura N, Ohta Y, Hirakata Y, Maki S, Hatamoto M, Yamaguchi T.

Environ Technol. 2018 Jun;39(12):1577-1585. doi: 10.1080/09593330.2017.1333530. Epub 2017 Jun 13.

PMID:
28593806
7.

Performance evaluation of the pilot scale upflow anaerobic sludge blanket - Downflow hanging sponge system for natural rubber processing wastewater treatment in South Vietnam.

Watari T, Mai TC, Tanikawa D, Hirakata Y, Hatamoto M, Syutsubo K, Fukuda M, Nguyen NB, Yamaguchi T.

Bioresour Technol. 2017 Aug;237:204-212. doi: 10.1016/j.biortech.2017.02.058. Epub 2017 Mar 7.

PMID:
28318934
8.

Development of downflow hanging sponge (DHS) reactor as post treatment of existing combined anaerobic tank treating natural rubber processing wastewater.

Watari T, Cuong Mai T, Tanikawa D, Hirakata Y, Hatamoto M, Syutsubo K, Fukuda M, Nguyen NB, Yamaguchi T.

Water Sci Technol. 2017 Jan;75(1-2):57-68. doi: 10.2166/wst.2016.487.

PMID:
28067646
9.

Microbial community analysis using MiSeq sequencing in a novel configuration fluidized bed reactor for effective denitrification.

Rungkitwatananukul P, Nomai S, Hirakata Y, Pungrasmi W, Puprasert C, Hatamoto M, Yamaguchi T.

Bioresour Technol. 2016 Dec;221:677-681. doi: 10.1016/j.biortech.2016.09.051. Epub 2016 Sep 14.

PMID:
27641252
10.

Effects of Predation by Protists on Prokaryotic Community Function, Structure, and Diversity in Anaerobic Granular Sludge.

Hirakata Y, Oshiki M, Kuroda K, Hatamoto M, Kubota K, Yamaguchi T, Harada H, Araki N.

Microbes Environ. 2016 Sep 29;31(3):279-87. doi: 10.1264/jsme2.ME16067. Epub 2016 Jul 12.

11.

Clinical and molecular epidemiological features of tuberculosis after the 2011 Japan earthquake and tsunami.

Kanamori H, Hatakeyama T, Uchiyama B, Weber DJ, Takeuchi M, Endo S, Hirakata Y, Kaku M.

Int J Tuberc Lung Dis. 2016 Apr;20(4):505-14. doi: 10.5588/ijtld.15.0607.

PMID:
26970161
12.

Identification and Detection of Prokaryotic Symbionts in the Ciliate Metopus from Anaerobic Granular Sludge.

Hirakata Y, Oshiki M, Kuroda K, Hatamoto M, Kubota K, Yamaguchi T, Harada H, Araki N.

Microbes Environ. 2015;30(4):335-8. doi: 10.1264/jsme2.ME15154. Epub 2015 Dec 4.

13.

A case of Manila type Mycobacterium tuberculosis infection in Japan.

Usami O, Nakajima C, Endo S, Inomata S, Kanamori H, Hirakata Y, Uchiyama B, Kaku M, Suzuki Y, Hattori T.

Clin Case Rep. 2015 Jul;3(7):622-5. doi: 10.1002/ccr3.277. Epub 2015 Jun 5.

14.

Overexpression of androgen receptor and forkhead-box A1 protein in apocrine breast carcinoma.

Sasahara M, Matsui A, Ichimura Y, Hirakata Y, Murata Y, Marui E.

Anticancer Res. 2014 Mar;34(3):1261-7.

PMID:
24596370
15.

Lessons learned from earthquake-related tuberculosis exposures in a community shelter, Japan, 2011.

Kanamori H, Kimura R, Weber DJ, Uchiyama B, Hirakata Y, Aso N, Kiryu K, Kaku M.

Am J Infect Control. 2014 Mar;42(3):246-8. doi: 10.1016/j.ajic.2013.10.004.

PMID:
24581013
16.

Influence of prior pandemic A(H1N1)2009 virus infection on invasion of MDCK cells by community-associated methicillin-resistant Staphylococcus aureus.

Takayama Y, Yano H, Nojima Y, Nakano R, Okamoto R, Hirakata Y, Sunakawa K, Akahoshi T, Kaku M.

J Infect Chemother. 2014 Jan;20(1):71-3. doi: 10.1016/j.jiac.2013.07.012. Epub 2013 Dec 11.

PMID:
24462431
17.

Improvement rate of acute otitis media caused by Haemophilus influenzae at 1 week is significantly associated with time to recovery.

Yano H, Yamazaki Y, Qin L, Okitsu N, Yahara K, Irimada M, Hirakata Y, Kaku M, Kobayashi T, Watanabe H.

J Clin Microbiol. 2013 Nov;51(11):3542-6. doi: 10.1128/JCM.01108-13. Epub 2013 Aug 21.

18.

Lessons learned from a tuberculosis contact investigation associated with a disaster volunteer after the 2011 Great East Japan Earthquake.

Kanamori H, Uchiyama B, Hirakata Y, Chiba T, Okuda M, Kaku M.

Am J Respir Crit Care Med. 2013 Jun 1;187(11):1278-9. doi: 10.1164/rccm.201212-2150LE. No abstract available.

PMID:
23725629
19.

Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital.

Yano H, Uemura M, Endo S, Kanamori H, Inomata S, Kakuta R, Ichimura S, Ogawa M, Shimojima M, Ishibashi N, Aoyagi T, Hatta M, Gu Y, Yamada M, Tokuda K, Kunishima H, Kitagawa M, Hirakata Y, Kaku M.

PLoS One. 2013 May 15;8(5):e64359. doi: 10.1371/journal.pone.0064359. Print 2013.

20.

Tuberculosis exposure among evacuees at a shelter after earthquake, Japan, 2011.

Kanamori H, Aso N, Tadano S, Saito M, Saito H, Uchiyama B, Ishibashi N, Inomata S, Endo S, Aoyagi T, Hatta M, Yamada M, Gu Y, Tokuda K, Yano H, Kunishima H, Hirakata Y, Saijyo T, Kitagawa M, Kaku M.

Emerg Infect Dis. 2013 May;19(5):799-801. doi: 10.3201/eid1905.121137.

21.

Identification of Actinomyces meyeri actinomycosis in middle ear and mastoid by 16S rRNA analysis.

Kakuta R, Hidaka H, Yano H, Miyazaki H, Suzaki H, Nakamura Y, Kanamori H, Endo S, Hirakata Y, Kaku M, Kobayashi T.

J Med Microbiol. 2013 Aug;62(Pt 8):1245-8. doi: 10.1099/jmm.0.051698-0. Epub 2013 May 2.

PMID:
23639988
22.

The capability of MRSA active surveillance to reduce MRSA infection in Japan.

Kanemitsu K, Yamamoto N, Imafuku Y, Mitsutake K, Miyazato A, Takemura H, Terakubo S, Matsuda T, Kazuhisa Y, Hirakata Y, Kaku M.

Am J Infect Control. 2013 May;41(5):470-1. doi: 10.1016/j.ajic.2012.07.020. Epub 2012 Dec 23. No abstract available.

PMID:
23267743
23.

Characteristics of infectious diseases in hospitalized patients during the early phase after the 2011 great East Japan earthquake: pneumonia as a significant reason for hospital care.

Aoyagi T, Yamada M, Kunishima H, Tokuda K, Yano H, Ishibashi N, Hatta M, Endo S, Arai K, Inomata S, Gu Y, Kanamori H, Kitagawa M, Hirakata Y, Kaku M.

Chest. 2013 Feb 1;143(2):349-356. doi: 10.1378/chest.11-3298.

PMID:
22911275
24.

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131.

Kuroda H, Yano H, Hirakata Y, Arai K, Endo S, Kanamori H, Yamamoto H, Ichimura S, Ogawa M, Shimojima M, Komatsu M, Jonai T, Itagaki S, Nonomiya Y, Suwabe A, Kaku M.

Diagn Microbiol Infect Dis. 2012 Oct;74(2):201-3. doi: 10.1016/j.diagmicrobio.2012.06.011. Epub 2012 Jul 12.

PMID:
22796185
25.

IMP-1-producing carbapenem-resistant Acinetobacter ursingii from Japan.

Endo S, Sasano M, Yano H, Inomata S, Ishibashi N, Aoyagi T, Hatta M, Gu Y, Yamada M, Tokuda K, Kitagawa M, Kunishima H, Hirakata Y, Kaku M.

J Antimicrob Chemother. 2012 Oct;67(10):2533-4. doi: 10.1093/jac/dks249. Epub 2012 Jun 25. No abstract available.

PMID:
22733654
26.

Molecular characteristics of extended-spectrum beta-lactamases and qnr determinants in Enterobacter species from Japan.

Kanamori H, Yano H, Hirakata Y, Hirotani A, Arai K, Endo S, Ichimura S, Ogawa M, Shimojima M, Aoyagi T, Hatta M, Yamada M, Gu Y, Tokuda K, Kunishima H, Kitagawa M, Kaku M.

PLoS One. 2012;7(6):e37967. doi: 10.1371/journal.pone.0037967. Epub 2012 Jun 15.

27.

Bacteriophage control of vancomycin-resistant enterococci in cattle compost.

Otawa K, Hirakata Y, Kaku M, Nakai Y.

J Appl Microbiol. 2012 Sep;113(3):499-507. doi: 10.1111/j.1365-2672.2012.05361.x. Epub 2012 Jul 12.

28.

High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan.

Yano H, Ogawa M, Endo S, Kakuta R, Kanamori H, Inomata S, Ishibashi N, Aoyagi T, Hatta M, Gu Y, Yamada M, Tokuda K, Kunishima H, Kitagawa M, Hirakata Y, Kaku M.

Antimicrob Agents Chemother. 2012 Aug;56(8):4554-5. doi: 10.1128/AAC.00617-12. Epub 2012 Jun 4. No abstract available.

29.

Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.

Endo S, Yano H, Hirakata Y, Arai K, Kanamori H, Ogawa M, Shimojima M, Ishibashi N, Aoyagi T, Hatta M, Yamada M, Tokuda K, Kitagawa M, Kunishima H, Kaku M.

J Antimicrob Chemother. 2012 Jul;67(7):1623-6. doi: 10.1093/jac/dks094. Epub 2012 Mar 23.

PMID:
22447879
30.

A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings.

Miyasaka T, Aoyagi T, Uchiyama B, Oishi K, Nakayama T, Kinjo Y, Miyazaki Y, Kunishima H, Hirakata Y, Kaku M, Kawakami K.

Vaccine. 2012 May 9;30(22):3304-10. doi: 10.1016/j.vaccine.2012.03.007. Epub 2012 Mar 15.

PMID:
22426326
31.

First carbapenem-resistant isolates of Acinetobacter soli in Japan.

Endo S, Sasano M, Yano H, Arai K, Aoyagi T, Hatta M, Gu Y, Yamada M, Tokuda K, Ogawa M, Shimojima M, Kitagawa M, Kunishima H, Hirakata Y, Kaku M.

Antimicrob Agents Chemother. 2012 May;56(5):2786-7. doi: 10.1128/AAC.00021-12. Epub 2012 Feb 21. No abstract available.

32.

Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa.

Hirakata Y, Yano H, Arai K, Kitagawa M, Hatta M, Kunishima H, Kaku M.

J Infect Chemother. 2012 Jun;18(3):347-51. doi: 10.1007/s10156-011-0342-y. Epub 2011 Nov 25.

PMID:
22116462
33.

Post-tsunami outbreaks of influenza in evacuation centers in Miyagi Prefecture, Japan.

Hatta M, Endo S, Tokuda K, Kunishima H, Arai K, Yano H, Ishibashi N, Aoyagi T, Yamada M, Inomata S, Kanamori H, Gu Y, Kitagawa M, Hirakata Y, Kaku M.

Clin Infect Dis. 2012 Jan 1;54(1):e5-7. doi: 10.1093/cid/cir752. Epub 2011 Oct 5.

PMID:
21976468
34.
35.

[Acinetobacter spp. infections].

Hirakata Y.

Kansenshogaku Zasshi. 2011 Jul;85(4):340-6. Japanese.

PMID:
21861436
36.

Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.

Kanamori H, Navarro RB, Yano H, Sombrero LT, Capeding MR, Lupisan SP, Olveda RM, Arai K, Kunishima H, Hirakata Y, Kaku M.

Acta Trop. 2011 Oct-Nov;120(1-2):140-5. doi: 10.1016/j.actatropica.2011.07.007. Epub 2011 Jul 28.

PMID:
21820398
37.

High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2.

Kanamori H, Yano H, Hirakata Y, Endo S, Arai K, Ogawa M, Shimojima M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Kitagawa M, Kunishima H, Kaku M.

J Antimicrob Chemother. 2011 Oct;66(10):2255-62. doi: 10.1093/jac/dkr283. Epub 2011 Jul 6.

PMID:
21733965
38.

Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes.

Aoyagi T, Yamamoto N, Hatta M, Tanno D, Miyazato A, Ishii K, Suzuki K, Nakayama T, Taniguchi M, Kunishima H, Hirakata Y, Kaku M, Kawakami K.

Int Immunol. 2011 Feb;23(2):97-108. doi: 10.1093/intimm/dxq460. Epub 2010 Dec 20.

PMID:
21172897
39.

Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.

Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y, Yamamoto N, Kunishima H, Kaku M.

J Antimicrob Chemother. 2011 Mar;66(3):494-8. doi: 10.1093/jac/dkq477. Epub 2010 Dec 15.

PMID:
21172783
40.

Development of interpretive criteria for tebipenem disk diffusion susceptibility testing with Staphylococcus spp. and Haemophilus influenzae.

Fujisaki M, Sadamoto S, Ikedo M, Totsuka K, Kaku M, Tateda K, Hirakata Y, Yamaguchi K.

J Infect Chemother. 2011 Feb;17(1):17-23. doi: 10.1007/s10156-010-0091-3. Epub 2010 Jul 31.

PMID:
20676913
41.

Two patients who developed leptospirosis-associated acute renal failure within the same season.

Yamashita H, Furusu A, Nishino T, Obata Y, Miyazaki M, Ichinose H, Higashiyama Y, Ishino T, Koizumi N, Hirakata Y, Kohno S.

Intern Med. 2010;49(12):1143-7. Epub 2010 Jun 15.

42.

Methicillin resistant Staphylococcus aureus in a Japanese community hospital: 5-year experience.

Kunishima H, Yamamoto N, Kobayashi T, Minegishi M, Nakajima S, Chiba J, Kitagawa M, Hirakata Y, Honda Y, Kaku M.

J Infect Chemother. 2010 Dec;16(6):414-7. doi: 10.1007/s10156-010-0076-2. Epub 2010 Jun 9.

PMID:
20532940
43.

Activation of myeloid dendritic cells by deoxynucleic acids from Cordyceps sinensis via a Toll-like receptor 9-dependent pathway.

Xiao G, Miyazato A, Abe Y, Zhang T, Nakamura K, Inden K, Tanaka M, Tanno D, Miyasaka T, Ishii K, Takeda K, Akira S, Saijo S, Iwakura Y, Adachi Y, Ohno N, Yamamoto N, Kunishima H, Hirakata Y, Kaku M, Kawakami K.

Cell Immunol. 2010;263(2):241-50. doi: 10.1016/j.cellimm.2010.04.006. Epub 2010 Apr 20.

PMID:
20451901
44.

Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapy.

Lynch SV, Flanagan JL, Sawa T, Fang A, Baek MS, Rubio-Mills A, Ajayi T, Yanagihara K, Hirakata Y, Kohno S, Misset B, Nguyen JC, Wiener-Kronish JP.

Microb Pathog. 2010 Jun;48(6):197-204. doi: 10.1016/j.micpath.2010.02.008. Epub 2010 Mar 6.

45.

Monolayer culture systems with respiratory epithelial cells for evaluation of bacterial invasiveness.

Hirakata Y, Yano H, Arai K, Endo S, Kanamori H, Aoyagi T, Hirotani A, Kitagawa M, Hatta M, Yamamoto N, Kunishima H, Kawakami K, Kaku M.

Tohoku J Exp Med. 2010 Jan;220(1):15-9.

46.

Early production of tumor necrosis factor-alpha by Gr-1 cells and its role in the host defense to pneumococcal infection in lungs.

Hatta M, Yamamoto N, Miyazato A, Ishii N, Nakamura K, Inden K, Aoyagi T, Kunishima H, Hirakata Y, Suzuki K, Kaku M, Kawakami K.

FEMS Immunol Med Microbiol. 2010 Mar;58(2):182-92. doi: 10.1111/j.1574-695X.2009.00616.x. Epub 2009 Nov 10.

47.

[Drug susceptibility of bacteria isolated from pediatric respiratory infections at general practitioners' clinics to pediatric antibiotics].

Hirakata Y, Komatsu M, Muratani T, Kaku M.

Jpn J Antibiot. 2009 Apr;62(2):90-102. Japanese.

PMID:
19673351
48.

Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.

Hirakata Y, Ohmori K, Mikuriya M, Saika T, Matsuzaki K, Hasegawa M, Hatta M, Yamamoto N, Kunishima H, Yano H, Kitagawa M, Arai K, Kawakami K, Kobayashi I, Jones RN, Kohno S, Yamaguchi K, Kaku M.

Antimicrob Agents Chemother. 2009 Oct;53(10):4225-30. doi: 10.1128/AAC.00192-09. Epub 2009 Aug 3.

49.

Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.

Hirakata Y, Kondo A, Hoshino K, Yano H, Arai K, Hirotani A, Kunishima H, Yamamoto N, Hatta M, Kitagawa M, Kohno S, Kaku M.

Int J Antimicrob Agents. 2009 Oct;34(4):343-6. doi: 10.1016/j.ijantimicag.2009.06.007. Epub 2009 Jul 16.

PMID:
19615866
50.

In vitro activity of garenoxacin against Streptococcus pneumoniae mutants with characterized resistance mechanisms.

Yamamoto K, Yanagihara K, Sugahara K, Imamura Y, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Hirakata Y, Kamihira S, Kohno S.

Antimicrob Agents Chemother. 2009 Aug;53(8):3572-5. doi: 10.1128/AAC.00176-09. Epub 2009 May 18.

Supplemental Content

Loading ...
Support Center